![Robert Dishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Dishman
Directeur Général chez
Molecular Recognition, Inc.
Profil
Robert A. Dishman was the founder of Serenex, Inc. (founded in 2000) where he held the title of Chief Executive Officer & Director from 2000 to 2002, and BioFlash Partners LLC (founded in 2007) where he held the title of Director from 2011 to 2012.
Currently, he is the President & Chief Executive Officer at Molecular Recognition, Inc. since 2002.
Previously, he worked as Director & Executive Vice President at Dyax Corp.
from 1994 to 2000.
He also served as an Independent Director at Harvard Bioscience, Inc. from 2000 to 2015.
Additionally, he held positions as Director at BioSystem Development LLC, Tarpon Biosystems, Inc., and Advisor at Echelon Ventures.
He was also the Executive Vice President-Supply Chain at Nextlife, Inc. Dr. Dishman earned a doctorate degree from the University of Massachusetts and an undergraduate degree from the University of New Hampshire.
Postes actifs de Robert Dishman
| Sociétés | Poste | Début |
|---|---|---|
Molecular Recognition, Inc. | Directeur Général | 01/01/2002 |
Anciens postes connus de Robert Dishman
| Sociétés | Poste | Fin |
|---|---|---|
| HARVARD BIOSCIENCE, INC. | Directeur/Membre du Conseil | 28/04/2015 |
Echelon Ventures
 Echelon Ventures Investment ManagersFinance Echelon Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 30/08/2008 |
Serenex, Inc.
 Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Fondateur | 01/01/2002 |
| DYAX CORP. | Directeur Général | 01/08/1995 |
Tarpon Biosystems, Inc.
 Tarpon Biosystems, Inc. BiotechnologyHealth Technology Develops BioSMB systems | Directeur/Membre du Conseil | - |
Formation de Robert Dishman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
Serenex, Inc.
Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
BioSystem Development LLC
 BioSystem Development LLC Miscellaneous Commercial ServicesCommercial Services Provides and designs biotechnology and life science research services and applications | Commercial Services |
BioFlash Partners LLC
 BioFlash Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides bio technical research services | Commercial Services |
Tarpon Biosystems, Inc.
Tarpon Biosystems, Inc. BiotechnologyHealth Technology Develops BioSMB systems | Health Technology |
Echelon Ventures
Echelon Ventures Investment ManagersFinance Echelon Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextlife, Inc.
 Nextlife, Inc. Miscellaneous Commercial ServicesCommercial Services Provides environmental consulting services | Commercial Services |
Molecular Recognition, Inc. |
Choisissez Zonebourse 
